Get the Stockscreener App
4.83
0.92%
-0.045
After Hours:
4.81
-0.02
-0.41%
Lixte Biotechnology Holdings Inc stock is traded at $4.83, with a volume of 80,376.
It is down -0.92% in the last 24 hours and up +90.91% over the past month.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
See More
Previous Close:
$4.875
Open:
$4.78
24h Volume:
80,376
Relative Volume:
0.04
Market Cap:
$12.96M
Revenue:
-
Net Income/Loss:
$-4.69M
P/E Ratio:
-2.073
EPS:
-2.33
Net Cash Flow:
$-3.81M
1W Performance:
-0.82%
1M Performance:
+90.91%
6M Performance:
+96.34%
1Y Performance:
+123.61%
1-Day Range:
$4.42
$4.94
1-Week Range:
$4.20
$5.14
52-Week Range:
$0.64
$5.14
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
Name
Lixte Biotechnology Holdings Inc
Sector
Industry
Phone
310 203 2902
Address
248 ROUTE 25A, EAST SETAUKET
Compare LIXT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
4.83 | 13.56M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Lixte Biotechnology Holdings Inc Stock (LIXT) Latest News
LIXTE BIOTECHNOLOGY HOLDINGS, INC. SEC 10-Q Report - TradingView
Lixte Biotechnology Holdings Inc. Stock Lags Behind Sector BenchmarksTechnical Entry Strategy for Beginners Explained - beatles.ru
What institutional investors are buying Lixte Biotechnology Holdings Inc. Equity Warrant stock - Jammu Links News
What is the dividend policy of Lixte Biotechnology Holdings Inc. stockMaximize gains with expert analysis - Jammu Links News
Is Lixte Biotechnology Holdings Inc. stock overvalued or undervaluedConsistently exceptional gains - Jammu Links News
Is Lixte Biotechnology Holdings Inc. a growth stock or a value stockAchieve rapid portfolio growth with expert help - Jammu Links News
Why is Lixte Biotechnology Holdings Inc. Equity Warrant stock attracting strong analyst attention - Jammu Links News
How strong is Lixte Biotechnology Holdings Inc. company’s balance sheetDiscover high-impact investment opportunities - Jammu Links News
What are analysts’ price targets for Lixte Biotechnology Holdings Inc. in the next 12 monthsBuild wealth steadily with smart stock selection - Jammu Links News
Should I hold or sell Lixte Biotechnology Holdings Inc. Equity Warrant stock in 2025Get high-impact stock recommendations now - Jammu Links News
How many analysts rate Lixte Biotechnology Holdings Inc. as a “Buy”Build wealth steadily with smart stock selection - Jammu Links News
Is it the right time to buy Lixte Biotechnology Holdings Inc. Equity Warrant stockUnlock powerful stock screening tools today - Jammu Links News
Does Lixte Biotechnology Holdings Inc. Equity Warrant stock perform well during market downturnsDynamic capital growth - Jammu Links News
What catalysts could drive Lixte Biotechnology Holdings Inc. Equity Warrant stock higher in 2025Unlock expert insights for smarter investing - Jammu Links News
Does Lixte Biotechnology Holdings Inc. stock perform well during market downturnsInvest confidently with real-time data - Jammu Links News
What makes Lixte Biotechnology Holdings Inc. stock price move sharplyPhenomenal trading returns - Jammu Links News
What is Lixte Biotechnology Holdings Inc. Equity Warrant company’s growth strategyHigh-yield market plays - Jammu Links News
How strong is Lixte Biotechnology Holdings Inc. Equity Warrant company’s balance sheetUnlock exclusive trading strategies for gains - Jammu Links News
Published on: 2025-08-01 22:26:18 - metal.it
What is the risk reward ratio of investing in Lixte Biotechnology Holdings Inc. stockTop Growth Target Finder To Watch Now - Jammu Links News
Why Lixte Biotechnology Holdings Inc. stock attracts strong analyst attentionSmart Stock Forecast Using AI Algorithms - Newser
Best data tools to analyze Lixte Biotechnology Holdings Inc. Equity Warrant stockWeekly Setup Summary for Risk Controlled Trades - Newser
Can volume confirm reversal in Lixte Biotechnology Holdings Inc.Entry Alert With Low Drawdown Strategy Noted - metal.it
Lixte Biotechnology Holdings Inc. Company Revenue and Profit Trends: A Deep DiveIntraday Price Forecast Using Volume Models - Newser
What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock price move sharplyTrade Ideas Based on Fundamental Metrics - Newser
Recovery Setup Building in Lixte Biotechnology Holdings Inc. Experts SayStock Market Entry Timing Signals Revealed - metal.it
Lixte Biotechnology Holdings Inc. At Decision Level — Rebound or ResistanceDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
What to expect from Lixte Biotechnology Holdings Inc. Equity Warrant in the next 30 daysTactical Trade Setup With Entry Optimizer - Newser
Will breakout in Lixte Biotechnology Holdings Inc. Equity Warrant lead to full recoverySwing Trade Entry and Exit Point Analysis - Newser
Visual analytics tools that track Lixte Biotechnology Holdings Inc. Equity Warrant performanceSafe Entry Strategy with High Win Rate - Newser
Why Lixte Biotechnology Holdings Inc. Equity Warrant stock attracts strong analyst attentionEntry Timing Tracker with Alert Accuracy - Newser
Using RSI to spot recovery in Lixte Biotechnology Holdings Inc. Equity Warrant Free Alert Feed for Momentum Based Picks - metal.it
Lixte Biotechnology Holdings Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWeekly Growth Stock Entry Point Alerts Highlighted - metal.it
Regression analysis insights on Lixte Biotechnology Holdings Inc. performanceFree Safe Entry Stock Watch Suggestions - Newser
What the charts say about Lixte Biotechnology Holdings Inc. Equity Warrant today Free Real Market Momentum Signal Generator - Newser
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com
Is Lixte Biotechnology Holdings Inc. stock a good hedge against inflation3x Growth Potential - beatles.ru
Lixte Biotechnology Holdings Inc Stock (LIXT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
3.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):